MetS has been reported to be associated with an increased risk of developing OA (13) and with increased levels of leptin and interleukin-1 beta (IL-1β) in the plasma (14), suggesting that the presence of MetS may promote the development and progression of OA. This evidence concerns the gene IL1B and metabolic syndrome.